Page last updated: 2024-10-31

nabumetone and Acute Myelogenous Leukemia

nabumetone has been researched along with Acute Myelogenous Leukemia in 2 studies

Nabumetone: A butanone non-steroidal anti-inflammatory drug and cyclooxygenase-2 (COX2) inhibitor that is used in the management of pain associated with OSTEOARTHRITIS and RHEUMATOID ARTHRITIS.
nabumetone : A methyl ketone that is 2-butanone in which one of the methyl hydrogens at position 4 is replaced by a 6-methoxy-2-naphthyl group. A prodrug that is converted to the active metabolite, 6-methoxy-2-naphthylacetic acid, following oral administration. It is shown to have a slightly lower risk of gastrointestinal side effects than most other non-steroidal anti-inflammatory drugs.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nakanishi, Y1
Kamijo, R1
Takizawa, K1
Hatori, M1
Nagumo, M1
Burnett, D1
Crocker, J1
Afford, SC1
Bunce, CM1
Brown, G1
Stockley, RA1

Other Studies

2 other studies available for nabumetone and Acute Myelogenous Leukemia

ArticleYear
Inhibitors of cyclooxygenase-2 (COX-2) suppressed the proliferation and differentiation of human leukaemia cell lines.
    European journal of cancer (Oxford, England : 1990), 2001, Volume: 37, Issue:12

    Topics: Antineoplastic Agents; Blotting, Western; Butanones; Cell Division; Cell Transformation, Neoplastic;

2001
Cathepsin B synthesis by the HL60 promyelocytic cell line: effects of stimulating agents and anti-inflammatory compounds.
    Biochimica et biophysica acta, 1986, Aug-01, Volume: 887, Issue:3

    Topics: Anti-Inflammatory Agents; Butanones; Carboxylesterase; Carboxylic Ester Hydrolases; Carrageenan; Cat

1986